Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Jan-Mar;168(1):25-8.
doi: 10.1007/BF02939576.

An audit of the effect of intravenous antibiotic treatment on spirometric measures of pulmonary function in cystic fibrosis

J M Bradley  1 , E S Wallace, J S Elborn, J L Howard, M P McCoy
Affiliations
Comparative Study

An audit of the effect of intravenous antibiotic treatment on spirometric measures of pulmonary function in cystic fibrosis

J M Bradley et al. Ir J Med Sci. 1999 Jan-Mar.

Abstract

Background: This retrospective audit was undertaken to compare the efficacy of home intravenous (i.v.) antibiotic therapy, hospital i.v. antibiotic therapy and a combination of these 2 approaches, as determined by spirometric measures of lung function in cystic fibrosis (CF) patients, each with an acute respiratory exacerbation.

Methods: Pulmonary function, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), forced expiratory flow rate between 25 per cent and 75 per cent of vital capacity (FEF25-75), and peak expiratory flow rate (PEFR) were compared between groups at the beginning and at the end of an IV antibiotic course.

Results: Treatment of exacerbations resulted in a significant improvement (p < 0.05) in lung function irrespective of where patients were treated. The percentage improvement in FEV1, FVC, and FEF25-75, were significantly greater in patients treated in hospital compared to those who had home i.v. treatment (p < 0.05).

Conclusion: Hospital i.v. antibiotic therapy resulted in greater improvements in FEV1, FVC and FEF25-75 than home i.v. antibiotic therapy in CF patients with an acute respiratory infection.

PubMed Disclaimer

References

    1. Am Rev Respir Dis. 1976 Dec;114(6):1085-92 - PubMed
    1. Eur Respir J. 1994 Sep;7(9):1640-4 - PubMed
    1. J Pediatr. 1987 Jul;111(1):28-33 - PubMed
    1. Thorax. 1994 Feb;49(2):115-20 - PubMed
    1. Arch Dis Child. 1988 May;63(5):512-7 - PubMed

Publication types

Substances